Part 3 U.K. Drugs, Medicines and Pharmacies

Chapter 1 U.K. Supervision of management and use of controlled drugs

25 Interpretation U.K.

(1) In this Chapter—

• “accountable officer” is to be read in accordance with section 17(2);

• “body” includes an unincorporated association;

• “controlled drug” has the meaning given by section 2 of the Misuse of Drugs Act 1971 (c. 38);

• “designated body” has the meaning given by section 17(3);

• “health care” means—

  (a)

  services provided to individuals for or in connection with the prevention, diagnosis or treatment of illness, and

  (b)

  the promotion and protection of public health;

• “health care professional”—

  (a)

  in relation to England and Wales, has the meaning given by [F1 section 91(2)(a) of the National Health Service Act 2006 (referred to in this Act as “the 2006 Act”)],

  (b)

  in relation to Scotland, has the meaning given by section 17D(2) of the National Health Service (Scotland) Act 1978 (c. 29), and

  (c)

  in relation to Northern Ireland, has the meaning given by Article 15C of the Health and Personal Social Services (Northern Ireland) Order 1972 (S.I. 1972/1265 (N.I. 14));

• “illness”—

  (a)

  in relation to England and Wales, has the meaning given by [F2 section 275 of the 2006 Act],

  (b)

  in relation to Scotland, has the meaning given by section 108(1) of the National Health Service (Scotland) Act 1978, and

  (c)

  in relation to Northern Ireland, has the meaning given by Article 2(2) of the Health and Personal Social Services (Northern Ireland) Order 1972;

• “relevant authority” is to be read in accordance with section 24;

• “relevant records” has the meaning given by section 20(9);

• “responsible body” has the meaning given by section 18(2).

(2) In this Chapter any reference to the management or use of controlled drugs includes—

(a) the storage, carriage and safe custody of such drugs,

(b) the prescribing and supply of such drugs,

(c) the administration of such drugs,

(d) the recovery of such drugs when no longer needed, and

(e) the disposal of such drugs.

Textual Amendments

F1 Words in s. 25(1) substituted (1.3.2007) by National Health Service (Consequential Provisions) Act 2006 (c. 43), s. 8(2), Sch. 1 para. 282(a) (with Sch. 3 Pt. 1)

F2 Words in s. 25(1) substituted (1.3.2007) by National Health Service (Consequential Provisions) Act 2006 (c. 43), s. 8(2), Sch. 1 para. 282(b) (with Sch. 3 Pt. 1)

Commencement Information

I1 S. 25 in force for certain purposes at Royal Assent, see s. 83

I2 S. 25 in force at 1.1.2007 for E. in so far as not already in force by S.I. 2006/3125, art. 2(1)

I3 S. 25 in force at 1.3.2007 for S. in so far as not already in force by S.I. 2006/3125, art. 2(2)

I4 S. 25 in force at 13.12.2008 for W. in so far as not already in force by S.I. 2008/3171, art. 2(a)

I5 S. 25 in force at 1.8.2012 for N.I. in so far as not already in force by S.R. 2012/307, art. 2(a)